Clinical Trials

Showing trials with last updates posted in 2024.

NCT03199040 | TERMINATED | PHASE1
18 participants

Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2024-05-28
Start Date:
2019-07-23
Completion:
2022-11-21
Conditions
  • Triple Negative Breast Cancer
  • Triple Negative Breast Neoplasms
  • TNBC - Triple-Negative Breast Cancer
  • Triple-negative Breast Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
  • DEVICE
  • PROCEDURE
Previous
Sorted by latest updates
Next
Showing 40 trials per page